($) USD (Default)
  • ($) AUD
  • (€) EUR
  • ($) CAD
  • ($) NZD
  • (£) GBP

TB500 Nasal Spray

$26.95$47.48

The TB500 Nasal Spray presents an innovative approach to administering synthetic Thymosin Beta-4 through the nasal mucosa, aiming for quicker absorption into the bloodstream. This method seeks to boost its efficacy and potentially speed up the benefits of tissue repair and healing.

15ml Nasal Spray contains 2mg TB500
30ml Nasal Spray contains 4mg TB500

416 in stock

First time customer gets 15% discount code = 1storder

TB500 Nasal Spray

The TB500 Nasal Spray is an innovative delivery system designed for applying synthetic Thymosin Beta-4 directly through the nasal mucosa, facilitating a more direct route to the bloodstream compared to traditional administration methods. This innovative approach aims to enhance the bioavailability and efficiency of Thymosin Beta-4, potentially accelerating its therapeutic effects on tissue repair, regeneration, and healing.

Similar to our TB500 Peptide Vial, the nasal spray is formulated for research purposes, allowing scientists to explore alternative administration routes and their impact on the compound’s efficacy in promoting cellular growth, migration, and proliferation. The TB500 Nasal Spray stands as a testament to our commitment to advancing research methodologies and enhancing the accessibility of Thymosin Beta-4 for scientific study.

For more information on the benefits and specifications of TB500, please explore our primary category page.


TB500 Nasal Spray Benefits

Enhanced Bioavailability: The TB500 Nasal Spray’s delivery method enhances Thymosin Beta-4’s bioavailability, ensuring more efficient absorption into the bloodstream.

Rapid Effect: Due to its direct transmission through the nasal mucosa, the nasal spray can potentially expedite the therapeutic effects on tissue repair and healing.

User Convenience: Offers a non-invasive and easy-to-administer alternative, making it more convenient for researchers to handle and apply.

Increased Efficacy: By bypassing the digestive system, the nasal spray may increase the compound’s efficacy, maximising its therapeutic potential in research settings.

Innovative Approach: Represents a novel administration route that opens new avenues for scientific investigation into the effects and benefits of Thymosin Beta-4.


References:

[1] E.G. Yarmola, E.S. Klimenko, G. Fujita, M.R. Bubb (2007) Thymosin beta4: actin regulation and more – Annals of the New York Academy of Sciences, 2007 Sep, Volume 1112, Pages 76-85.


ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.
DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Direct Sarms website is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.

You may also like…